Dr. Gissou Azabdaftari

Gissou Azabdaftari

MD

Specializing In:

Oncologic surgical pathology with emphasis on genito-urologic tumors Bone and soft tissue tumors Cytology

Special Interests:

Histo-morphologic diagnosis, classification and staging of urologic and male organ genitals, bone and soft tissue tumors Translational research and tissue banking Performing and interpretation of fine needle aspirations
Credentials

Positions

Roswell Park Comprehensive Cancer Center
  • Chief, Division of Cytopathology
  • Associate Professor of Oncology
  • Department of Pathology & Laboratory Medicine
  • Department of Urology

Background

Education and Training:

  • 1987-1994 - University of Bologna, Bologna, Italy

Residency:

  • 2000-2004 - Tufts-New England Medical Center, Boston, MA

Fellowship:

  • 2005-2006 - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (Cytopathology)
  • 2004-2005 - Brigham and Women's Hospital, Harvard Medical School, Boston, MA (Genitourinary Pathology/Soft Tissue Pathology)

Board Certification:

  • Board Certified in Anatomic Pathology
  • American Board of Cytopathology

Professional Memberships:

  • United States and Canadian Academy of Pathology
  • American Society for Clinical Pathology
  • College of American Pathologists

Publications

  • Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, Huss WJ (2013) “Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme”, PLoS ONE 8(1): e55062. doi:10.1371/journal.pone.0055062.
  • Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D, Manhardt C, Lorusso GD, Willard SS, Thompson H, Shourideh M, Rezaei K, Sartor O, Mohler JL, Vessella RL, “Serum Glutamate Levels Correlate with Gleason’s Score and Glutamate Blockade Decreases, Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells”, Clin. Cancer Res., 2012; In Press.
  • Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. Journal of biological chemistry 2012; 28729:24832-24843
  • Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, Feng J. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nature communications 2012; 3:668
  • Koochekpour S, Hu S, Vellasco-Gonzalez C, Bernardo R, Azabdaftari G, Zhu G, Zhau HE, Chung LWK, Vessella RL. Serum prosaposin levels are increased in patients with advanced prostate cancer.Prostate 2012; 723:253-269
  • Ellis L, Shah P, Hammers H, Lehet K, Sotomayor P, Azabdaftari G, Seshadri M, Pili R. Vascular disruption in combination with mTOR inhibition in renal cell carcinoma. Molecular cancer therapeutics 2012;112:383-392
  • Azabdaftari G, Goldberg SN, Wang HH. Efficacy of on-site specimen adequacy evaluation of image-guided fine and core needle biopsies. Acta cytologica 2010; 542:132-137